0001209191-18-033657.txt : 20180529 0001209191-18-033657.hdr.sgml : 20180529 20180529070117 ACCESSION NUMBER: 0001209191-18-033657 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180524 FILED AS OF DATE: 20180529 DATE AS OF CHANGE: 20180529 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAVIOLETTE PAUL A CENTRAL INDEX KEY: 0001191249 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19437 FILM NUMBER: 18862915 MAIL ADDRESS: STREET 1: ONE BOSTON PLACE STREET 2: 201 WASHINGTON STREET, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSENTERIX INC. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-765-8400 MAIL ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: SafeStitch Medical, Inc. DATE OF NAME CHANGE: 20080211 FORMER COMPANY: FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC DATE OF NAME CHANGE: 19930328 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-05-24 0 0000876378 TRANSENTERIX INC. TRXC 0001191249 LAVIOLETTE PAUL A ONE BOSTON PLACE 201 WASHINGTON STREET, SUITE 3900 BOSTON MA 02108 1 0 0 0 Common Stock 2018-05-24 4 A 0 40950 A 40950 D Common Stock 7338352 I By LP Common Stock 208340 I By LP Stock Option Award 3.17 2018-05-24 4 A 0 71580 0.00 A 2028-05-24 Common Stock 71580 71580 D Represents restricted stock units. Each restricted stock unit represents the right to receive one share of the Registrant's common stock. The Reporting Person elected to receive his annual board of directors' compensation in equity. The restricted stock units remain subject to forfeiture until the first anniversary of the date of grant or, if earlier, the date of the next annual meeting of stockholders, as long as the reporting person remains in continuous service during the vesting period. Shares held by SV Life Sciences Fund IV, L.P. Paul LaViolette is a partner of SVLSF IV, LLC and a control person of SV Life Sciences Fund IV, L.P. Shares held by by SV Life Sciences Fund IV Strategic Partners, L.P. Paul LaViolette is a control person of SV Life Sciences Fund IV Strategic Partners, L.P. The vesting schedule is 25% of the stock option award on each of July 1, 2018, October 1, 2018, January 1, 2019 and April 1, 2019. /s/ Joshua Weingard attorney-in-fact for Paul A. LaViolette 2018-05-29